Physician profile
Christopher J Huser
NPI 1932206604
$14,017.34
in general payments reported to CMS, 2019-2025
61 companies · $1,559 in 2025
The $1,559 reported for 2025 was more than what 77% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,321 · 2020: $888 · 2021: $2,952 · 2022: $2,476 · 2023: $2,179 · 2024: $1,641 · 2025: $1,559.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,380.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,380.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,663.07 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16 |
| Abbvie INC. | $1,462.48 | 2021-2025 | |
| Collegium Pharmaceutical, INC. | $940.60 | 2019-2025 | Xtampza, Belbuca, Nucynta |
| Allergan, INC. | $590.21 | 2019-2022 | |
| Scilex Pharmaceuticals INC. | $478.91 | 2019-2025 | Ztlido |
| Amgen INC. | $474.04 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $442.64 | 2019-2025 | Relistor |
| Abbott Laboratories | $435.16 | 2020-2025 | Eterna, Proclaim |
| Lilly USA, LLC | $398.81 | 2019-2024 | Reyvow, Emgality |
| Lundbeck LLC | $364.52 | 2021-2025 | Vyepti |
| Zyla Life Sciences, INC. | $348.74 | 2019-2020 | |
| Mml US, INC. | $348.57 | 2022 | |
| Medtronic, INC. | $326.41 | 2021-2023 | Intellis Adaptivestim |
| Stimwave Technologies Incorporated | $303.86 | 2019 | |
| Pfizer INC. | $297.80 | 2019-2025 |
Show all 61 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Huser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.